Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc. > Voting Down The Midatech Deal

<< Previous

Bullboard Posts

Next >>

Comment by OttawaPeteron Jan 25, 2023 11:13am

83 Views

Post# 35245181

RE:Voting Down The Midatech Deal

Boomskid wrote:
It should be noted that the Midatech deal remains on the AGM agenda. Voting it up or down can still take place, even though the vote will not directly change things.

If the deal is not specifically voted down, DrDR may try to make the case that because the Bioasis shareholders approved it and if the Midatech shareholders had not voted it down then the deal would have gone through.

So, unless the Midatech is specifically voted down, DrDR may make the case that the door remains open for such a deal, that it could because the shareholders approved the old deal.

I think shareholders ought to vote on this even though it cannot mean that the old deal can go through. DrDR has a practice of squeezing all meaning she can from some things, and yet avoiding the meaning of other things, whichever suits her own judgement or agenda.

Has the Bioasis/Midatech-corporate presentation been left on the Bioasis website on purpose?

jd